Cryo-Cell International Inc logo

Cryo-Cell International Inc

AMEX:CCEL (USA)  
$ 7.46 -0.54 (-6.75%) 11:08 PM EST
At Loss
Market Cap:
$ 61.82M
Enterprise V:
$ 71.73M
Volume:
38.04K
Avg Vol (2M):
12.12K
Also Trade In:
Volume:
38.04K
At Loss
Avg Vol (2M):
12.12K

Business Description

Description
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.
Name Current Vs Industry Vs History
Cash-To-Debt 0.09
Equity-to-Asset -0.18
Debt-to-Equity -0.99
Debt-to-EBITDA -1.05
Interest Coverage 2.82
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.56
Distress
Grey
Safe
Beneish M-Score -2.71
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 66.23
9-Day RSI 68.47
14-Day RSI 67.15
6-1 Month Momentum % -9.01
12-1 Month Momentum % 70.03

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.45
Quick Ratio 0.42
Cash Ratio 0.05
Days Inventory 38.58
Days Sales Outstanding 75.14
Days Payable 120.93

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.2
Shareholder Yield % -7.55

Financials (Next Earnings Date:2024-04-19 Est.)

CCEL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with AMEX:CCEL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cryo-Cell International Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 31.344
EPS (TTM) ($) -1.14
Beta 0.37
Volatility % 120.07
14-Day RSI 67.15
14-Day ATR ($) 0.583012
20-Day SMA ($) 6.1245
12-1 Month Momentum % 70.03
52-Week Range ($) 2.95 - 8.15
Shares Outstanding (Mil) 8.29

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cryo-Cell International Inc Filings

Filing Date Document Date Form
No Filing Data

Cryo-Cell International Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Cryo-Cell International Inc Frequently Asked Questions

What is Cryo-Cell International Inc(CCEL)'s stock price today?
The current price of CCEL is $7.46. The 52 week high of CCEL is $8.15 and 52 week low is $2.95.
When is next earnings date of Cryo-Cell International Inc(CCEL)?
The next earnings date of Cryo-Cell International Inc(CCEL) is 2024-04-19 Est..
Does Cryo-Cell International Inc(CCEL) pay dividends? If so, how much?
Cryo-Cell International Inc(CCEL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1